Steiner Laboratories receives patent for compound to stimulate osteogenesis

NEW YORK, N.Y., USA: Steiner Laboratories, a leader in the field of bone regeneration, discovered the molecule necessary to regenerate the patient’s own bone. This technology eliminates the need for cadaver bone, the patient’s own harvested bone or animal bone and, more importantly, produces normal vital bone, the company asserts.